Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Wahana Ottomitra Multiartha Tbk. (WOMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Wahana Ottomitra Multiartha Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B), while Wahana Ottomitra Multiartha Tbk. trades at Rp248 (market cap 863.41B). The key difference: Wahana Ottomitra Multiartha Tbk. is far larger — about 2.8× Diagnos Laboratorium Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| DGNS | WOMF | |
|---|---|---|
Market Cap | 308B | 863.41B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Wahana Ottomitra Multiartha Tbk.
PT Wahana Ottomitra Multiartha Tbk (the Company) formerly PT Jakarta Tokyo Leasing, was established based on notarial deed No.179 dated March 23, 1982 of Kartini Muljadi SH, notary in Jakarta. The name was changed to PT Fuji Semeru Leasing on Dec 15 1982 and changed to PT Wahana Ometraco Multiartha on March 15, 2000. On November 30, 2004, the Company obtained the Effective Letter of the Registration Statement for the Initial Public Offering of Shares from the Chairman of the Capital Market Supervisory Agency (BAPEPAM) in its Letter No.S-3551/PM/2004. The Companys shares were listed on the Jakarta and Surabaya Stock Exchange (now Indonesia Stock Exchange) on December 13, 2004.
Read more on WOMF →
